Healthcare Analysts discuss Penumbra (PEN) STORM-PE Data on an Analyst/Industry conference call to be held on November 4.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEN:
- Penumbra Inc. Launches i-RISE Study to Enhance Stroke Treatment Insights
- Penumbra Inc.’s STRIKE-PE Study: A Game Changer for Pulmonary Embolism Treatment?
- Penumbra Inc.’s STRIDE II Study: A Promising Update for Investors
- Penumbra Inc.’s BOLT Study: A Game-Changer for Deep Vein Thrombosis Treatment?
- Penumbra reports positive results of vacuum thrombectomy in embolism trial
